Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms
Abstract
The nicotine abstinence syndrome was studied in the rat utilizing a modified rating scale of the opiate abstinence syndrome. Rats were infused with 10.27 mg/kg per day nicotine hydrogen tartrate for 7 days via subcutaneous minipumps. The behavior of each animal was observed before, during and after termination of the nicotine infusion. The abstinence signs in the withdrawal sessions included gasps, genital licks, ptosis, shakes, teeth chatter, yawns and changes in locomotor activity. Abstinence was induced through surgical removal of the pump or through administration of a nicotinic receptor antagonist, acting either centrally and peripherally (mecamylamine 1 mg/kg s.c.) or peripherally only (chlorisondamine 1 mg/kg s.c.). Statistical evaluation revealed a significant increase in overall abstinence signs both at 16 (P < 0.05) and 40 h (P < 0.01) after termination of the nicotine infusion, as compared to the number of signs in the nicotine treated animals' baseline sessions and to the number of signs in control animals (P < 0.05). There was also a significant reduction in locomotor activity during both withdrawal sessions. Animals injected with mecamylamine or chlorisondamine displayed a larger increase in the abstinence score (P < 0.001) than the spontaneously abstinent animals. Acute administration of different doses of nicotine or of the peripherally acting nicotinic receptor agonist tetramethylammonium (0.8 mg/kg s.c.) reversed the behavioral nicotine abstinence syndrome. Our results show that a nicotine abstinence syndrome can be elicited in rats on a chronic nicotine regimen either by acute withdrawal of nicotine or by the administration of nicotinic receptor antagonists and that peripheral nicotinic receptors may contribute significantly to the overall withdrawal reaction.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rodents chronically exposed to nicotine undergo a characteristic withdrawal syndrome that can occur spontaneously or be precipitated by mecamylamine.
“Rodents chronically exposed to nicotine undergo a characteristic withdrawal syndrome which develops spontaneously, after removing the nicotine source, or can be precipitated by administration of a nAChR antagonist such as mecamylamine [7, 11, 81, 163–166].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [164]
Cites
Induction of physical dependence upon ethanol and the associated behavioral changes in rats
Majchrowicz, E. (1975) · Psychopharmacologia · doi:10.1007/bf00429258 · Cited by 738 · see citing works
Smoking withdrawal symptoms in two weeks of abstinence
Shiffman, S. M., & Jarvik, M. E. (1976) · Psychopharmacology · doi:10.1007/bf00634151 · Cited by 548 · see citing works
Tolerance to and physical dependence on morphine in rats
Martin, W. R., Wikler, A., Eades, C. G., & Pescor, F. T. (1963) · Psychopharmacology · doi:10.1007/bf00408180 · Cited by 446 · see citing works
Ethanol withdrawal seizures and the NMDA receptor complex
Grant, K. A., Valverius, P., Hudspith, M. J., & Tabakoff, B. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90022-x · Cited by 431 · see citing works
Svensson, T. H. (1987) · Psychopharmacology · doi:10.1007/bf00215471 · Cited by 334 · see citing works
Self-citationRodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · see citing works
Characterization of the locomotor stimulant action of nicotine in tolerant rats
Clarke, P. B. S., & Kumar, R. C. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb10733.x · Cited by 222 · see citing works
Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol
Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., & Lal, H. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90078-2 · Cited by 194 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Birrell, C. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13248.x · Cited by 169 · see citing works
The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Ronald Lake, J., Carter, V. A., Scott Cunningham, J., Hebert, K. M., Conrad, D. L., & Wilson, O. B. (1994) · Psychopharmacology · doi:10.1007/bf02244770 · Cited by 165 · see citing works
Naloxone precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1993) · Psychopharmacology · doi:10.1007/bf02244930 · Cited by 147 · see citing works
Nicotine and smoking: a perspective from animal studies
Clarke, P. B. S. (1987) · Psychopharmacology · doi:10.1007/bf00177905 · Cited by 147 · see citing works
Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats
Levin, E. D., Morgan, M. M., Galvez, C., & Ellison, G. D. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90370-2 · Cited by 102 · see citing works
Clarke, P. B. S. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb16517.x · Cited by 62 · see citing works
El‐Bizri, H., & Clarke, P. B. S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17080.x · Cited by 51 · see citing works
Tung, C., Ugedo, L., Grenhoff, J., Engberg, G., & Svensson, T. H. (1989) · Synapse · doi:10.1002/syn.890040407 · Cited by 51 · see citing works
Self-citationEvidence for a behavioral deficit during withdrawal from chronic nicotine treatment
Corrigall, W. A., Herling, S., & Coen, K. M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90387-0 · Cited by 44 · see citing works
Nicotinic receptor blockade therapy and smoking cessation.
Clarke, P. B. S. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01797.x · Cited by 34 · see citing works
Engbergl, G., & Hajós, M. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169131 · Cited by 32 · see citing works
Meshul, C. K., Buckman, J. F., Allen, C., Riggan, J. P., & Feller, D. J. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199604)22:4 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674 · see citing works
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424 · see citing works
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · see citing works
Salas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · see citing works
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · see citing works
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse
Damaj, M. I., Kao, W., & Martin, B. R. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054908 · Cited by 222 · see citing works
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · see citing works
Jackson, K. J., Martin, B. R., Changeux, J. P., & Damaj, M. I. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132977 · Cited by 208 · see citing works
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200 · see citing works
Self-citationMalin, D. H. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00699-2 · Cited by 167 · see citing works
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140 · see citing works
Rada, P., Jensen, K., & Hoebel, B. (2001) · Psychopharmacology · doi:10.1007/s002130100781 · Cited by 141 · see citing works
Reduced dopamine d1 receptor binding in the ventral striatum of cigarette smokers
Dagher, A., Bleicher, C., Aston, J. A. D., Gunn, R. N., Clarke, P. B. S., & Cumming, P. (2001) · Synapse · doi:10.1002/syn.1098 · Cited by 132 · see citing works
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117 · see citing works
Rodent models of nicotine withdrawal syndrome
Malin, D. H., & Goyarzu, P. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_14 · Cited by 89 · see citing works
Besson, M., David, V., Suarez, S., Cormier, A., Cazala, P., Changeux, J.-P., & Granon, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0418-z · Cited by 73 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Shram, M. J., Siu, E. C. K., Li, Z., Tyndale, R. F., & Lê, A. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1115-x · Cited by 60 · see citing works
Kallupi, M., de Guglielmo, G., Larrosa, E., & George, O. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.08.299 · Cited by 25 · see citing works
Hamilton, K. R., Perry, M. E., Berger, S. S., & Grunberg, N. E. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq179 · Cited by 27 · see citing works
- Authors
- Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Psychopharmacology
- Published
- 1997-02-24
- Volume
- 129
- Issue
- 4
- Pages
- 348-356
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2093867596
- Cited by
- 122
- References
- 20
- Citations by year
- 2022: 1 · 2021: 4 · 2020: 1 · 2019: 4 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Svenska Läkaresällskapet
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine withdrawal, nicotinic antagonists, mecamylamine, chlorisondamine, tetramethylammonium, locomotor activity, rat behavior
- MeSH terms
- Animals, Behavior, Animal, Male, Nicotine, Substance Withdrawal Syndrome, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review